BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.260
-0.040 (-3.08%)
At close: Jun 23, 2026, 4:00 PM EDT
1.246
-0.014 (-1.10%)
After-hours: Jun 23, 2026, 7:58 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $38.91 million as of June 23, 2026. Its market cap has increased by 250.50% in one year.
Market Cap
38.91M
Enterprise Value
122.94M
1-Year Change
250.50%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $38.91M, a decrease of -76.79%. That is a compound annual growth rate of -16.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 38.91M | 11.16% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
| Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Oncology | 66.58M |
| InterCure | 58.14M |
| Talphera | 54.24M |
| Incannex Healthcare | 40.08M |
| SCYNEXIS | 39.42M |
| Zhengye Biotechnology Holding | 36.70M |
| China Pharma Holdings | 29.62M |
| Rockwell Medical | 27.04M |